Several in vivo studies showed that AD animal models fed with pomegranate are characterized by a reduction in reactive oxygen species formation, reduction of Aβ deposition thought BACE-1 inhibition, reduction in levels of hyperphosphorylation of the tau protein, and reduction of microglial activation. This evidence concerns the gene BACE1 and Alzheimer disease.